Buy, Hold, or Sell: Arm Holdings Shed 25% to Clear the Air as the Warsh Fed Digs In. Is It a Buy at $342?

At $342.23, Arm Holdings (NASDAQ:ARM) appears reasonably valued, with a much charismatic introduction constituent sitting astatine oregon beneath $310 connected immoderate macro-driven method consolidation. The banal has go the cleanest pure-play connected agentic AI infrastructure, but the circular travel from $100 to $428 and backmost to the mid-$300s successful six months argues for patience implicit chase.

Arm licenses the CPU architecture that powers virtually each smartphone connected world and is rapidly becoming the default compute level wrong hyperscale information centers. The institution has shipped implicit 350 cardinal chips and counts AWS, Google, Microsoft, NVIDIA, and Meta arsenic anchor customers. A 13.02% driblet implicit the past week, acceptable against a hawkish Warsh-led Fed signaling slower easing, has pulled long-duration tech backmost into focus.

The Bull Case: Agentic AI Demand Is Pulling Forward

Arm's pivot from royalty rents connected phones to dollar-rich information halfway silicon is real. Data halfway royalty gross much than doubled year-over-year successful Q4, and absorption disclosed much than $2 cardinal successful lawsuit request for the caller Arm AGI CPU crossed FY2027 and FY2028, with Meta signed arsenic pb co-development spouse for idiosyncratic superintelligence workloads targeting 3+ cardinal users.

NVIDIA Vera, Google Axion, Microsoft Cobalt, and AWS Graviton each tally Arm cores, and agentic AI requires much than 4x existent CPU capableness per gigawatt. Annual declaration worth reached $1.66 billion, up 22% year-over-year, and the information halfway CPU TAM is projected astatine implicit $100 cardinal by 2030. Mizuho's caller people hike to $500 reflects this re-rating.

The Bear Case: Valuation Has Lapped the Fundamentals

Arm trades astatine a trailing P/E of 357x and a guardant P/E of 147x, with a price-to-sales ratio of 67x. Q1 FY2027 guidance implies sequential gross of $1.26 cardinal with non-GAAP EPS of $0.40, and RPO decreased 7% year-over-year.

Non-GAAP R&D climbed 43% to $1.91 billion, compressing operating borderline from 52.8% to 49.1%. The Qualcomm/Nuvia proceedings is expected successful Q4 calendar 2026, SoftBank remains a controlling shareholder, and a beta of 3.79 means complaint scares deed this sanction first.